1.
HemoTypeSCTM Point-of-care Testing as a Screening Tool for Sickle Cell Disease among Newborns in Ilesa, Nigeria. Niger J Paediatr. 2026;53(1):20-27. doi:10.63270/njp.v53i1.2000045